Loading...
Indian Pharmaceutical Exporter · #4 for Domperidone · $1.6M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #4 Indian exporter of Domperidone with $1.6M in export value and 33 verified shipments. Macleods Pharmaceuticals Ltd holds a 5.6% market share in Domperidone exports across 4 countries.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANETPHARMA | FRANCE | $916.3K | 29 |
| ZUHOOR ELHAM LTD | PAKISTAN | $125.0K | 5 |
| FE ADVANCE PHARMACEUTICAL BUSINESS | UZBEKISTAN | $113.7K | 7 |
| PLANETPHARMA ZAC DU GRAND LAUNAY | FRANCE | $100.0K | 2 |
| PLANETPHARMA E GRAND | FRANCE | $50.0K | 1 |
| FE ADVANCE PHARMACEUTICAL | UZBEKISTAN | $44.7K | 4 |
| IBL LIMITED -HEALTH ACTIVE | MAURITIUS | $17.4K | 2 |
| IBL LTD- HEALTHACTIV | MAURITIUS | $12.0K | 2 |
Macleods Pharmaceuticals Ltd supplies Domperidone to 8 buyers globally. The largest buyer is PLANETPHARMA (FRANCE), followed by ZUHOOR ELHAM LTD (PAKISTAN) and FE ADVANCE PHARMACEUTICAL BUSINESS (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $15.3M worth of Domperidone through 4,195 shipments from 493 suppliers to 115 countries, serving 989 buyers globally. Macleods Pharmaceuticals Ltd contributes $1.6M to this total, accounting for 5.6% of India's Domperidone exports. Macleods Pharmaceuticals Ltd ships Domperidone to 4 countries through 8 buyers.
Macleods Pharmaceuticals Ltd's average Domperidone shipment value is $50.0K per consignment, based on 33 shipments totaling $1.6M. The largest destination is FRANCE (77.3% of Macleods Pharmaceuticals Ltd's Domperidone exports).
Macleods Pharmaceuticals Ltd ranks #4 among 493 Indian Domperidone exporters with a 5.6% market share. The top 3 exporters are COMBITIC GLOBAL CAPLET PRIVATE LIMITED ($4.3M), CADILA PHARMACEUTICALS LIMITED ($1.7M), INNOVA CAPTAB LIMITED ($1.6M). Macleods Pharmaceuticals Ltd processed 33 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NUPENTA DSR 40MG/10MG/20MG GEL B/30(PANTOPRAZOLE/DOMPERIDONE CAPSULES) NUPE100 3X10'S (19320 PAC) | $128.5K | 3 |
| NUPENTA DSR 40MG/10MG/20MG GEL B/30(PANTOPRAZOLE / DOMPERIDONE CAPSULES) NUPE1003X10S (15750 PAC)TBS | $105.6K | 3 |
| NUPENTA DSR PANTOPRAZOLE DOMPERIDONE40MG 30MG CAPSULES 3X10S 21760 PAC | $100.0K | 2 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES NUPENTA DSR/Pantoprazole with Domperidone Capsule | $100.0K | 2 |
| RABEMAC DSR 20MG/30MG GEL B/20(RABEPRAZOLE AND DOMPERIDONE CAPSULES) RABE227 2X10S (9100 PAC)TBS | $52.9K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES NUPENTA DSR/Pantoprazole with Domperidone Capsule | $50.0K | 1 |
| NUPENTA DSR 40MG/10MG/20MG GEL B/30PANTOPRAZOLE / DOMPERIDONE CAPSULES NUPE1003X10S 19145 PAC | $50.0K | 1 |
| RABEMAC DSR 20MG/30MG GEL B/20RABEPRAZOLE AND DOMPERIDONE CAPSULES RABE227 2X10S 18066 PAC | $50.0K | 1 |
| NUPENTA DSR 40MG/10MG/20MG GEL B/30PANTOPRAZOLE / DOMPERIDONE CAPSULES 3 X 10S TABLETS | $50.0K | 1 |
| NUPENTA D(PANTOPRAZOLE SODIUM AND DOMPERIDONE CAPSULES 20MG+10MG) 10X15S (72 PAC) | $50.0K | 1 |
Macleods Pharmaceuticals Ltd exports 35 distinct Domperidone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NUPENTA DSR 40MG/10MG/20MG GEL B/30(PANTOPRAZOLE/DOMPERIDONE with 3 shipments worth $128.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | CADILA PHARMACEUTICALS LIMITED | $1.7M | 90 | 8 | $19.1K |
| 2 | INNOVA CAPTAB LIMITED | $1.6M | 33 | 5 | $50.0K |
| 4 | MACLEODS PHARMACEUTICALS LTD ★ | $1.6M | 33 | 4 | $50.0K |
| 6 | MICRO LABS LIMITED | $1.0M | 87 | 15 | $11.9K |
| 7 | MEDREICH LIMITED | $843.6K | 33 | 3 | $25.6K |
Macleods Pharmaceuticals Ltd ranks #4 among 493 Indian Domperidone exporters. Average shipment value of $50.0K compared to the market average of $31.0K. The closest competitors by value are CADILA PHARMACEUTICALS LIMITED and INNOVA CAPTAB LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 503 | 12.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 487 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 332 | 7.9% |
| DELHI AIR | 251 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 224 | 5.3% |
| Bombay Air | 140 | 3.3% |
| JNPT/ NHAVA SHEVA SEA | 131 | 3.1% |
| JNPT | 124 | 3.0% |
Latest developments and market context
Detailed market intelligence for Domperidone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 989+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Domperidone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Domperidone. For current shipment-level data, contact TransData Nexus.